Solved

Why Is an Infusion of Muromonab-CD3 (Orthoclone)more Likely to Result

Question 29

Multiple Choice

Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than an infusion of mycophenolate (CellCept) ?


A) Muromonab-CD3 is administered for shorter time periods than is mycophenolate.
B) Muromonab-CD3 is administered in much higher dosages than is mycophenolate.
C) Mycophenolate is an antiproliferative agent and muromonab-CD3 is a polyclonal antibody.
D) Mycophenolate is a synthetically manufactured drug and muromonab-CD3 is produced using mouse proteins.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents